Cascade Investment Advisors’s Bristol-Myers Squibb BMY Stock Holding History

Cascade Investment Advisors’s Portfolio BMY Stock Details BMY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-300	Closed	-$20.8K	–	121
2023 Q1	$20.8K	Buy	+300	New	+$21.2K	0.02%	184
2022 Q3	–	Sell	-22,715	Closed	-$1.75M	–	116
2022 Q2	$1.75M	Sell	22,715 -4,782	-17%	-$364K	1.37%	7
2022 Q1	$2.01M	Sell	27,497 -503	-2%	-$33.8K	1.22%	14
2021 Q4	$1.75M	Buy	28,000 +665	+2%	+$39K	1.02%	30
2021 Q3	$1.62M	Buy	27,335 +505	+2%	+$33.3K	1.05%	32
2021 Q2	$1.79M	Sell	26,830 -25	-0.1%	-$1.63K	1.13%	23
2021 Q1	$1.7M	Buy	26,855 +1,370	+5%	+$85.2K	1.1%	26
2020 Q4	$1.58M	Sell	25,485 -10	-0%	-$615	1.16%	19
2020 Q3	$1.54M	Buy	25,495 +25	+0.1%	+$1.5K	1.3%	16
2020 Q2	$1.5M	Sell	25,470 -765	-3%	-$45.8K	1.41%	10
2020 Q1	$1.46M	Buy	26,235 +25	+0.1%	+$1.53K	1.61%	9
2019 Q4	$1.68M	Sell	26,210 -1,245	-5%	-$71.3K	1.29%	14
2019 Q3	$1.39M	Buy	27,455 +955	+4%	+$44.9K	1.07%	29
2019 Q2	$1.2M	Buy	26,500 +4,015	+18%	+$187K	1.02%	40
2019 Q1	$1.07M	Buy	22,485 +6,850	+44%	+$341K	0.96%	47
2018 Q4	$813K	Buy	15,635 +14,635	+1,464%	+$786K	0.82%	59
2018 Q3	$62.1K	Hold	1,000	–	–	0.05%	124
2018 Q2	$55.3K	Buy	+1,000	New	+$54K	0.05%	123
2016 Q2	$22.1K	Buy	+300	New	+$21.2K	0.02%	123

Other funds holding BMY

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Cascade Investment Advisors's BMY Position: Q2 2023 in Review

Cascade Investment Advisors sold out of Bristol-Myers Squibb (BMY) in Q2 2023, closing a stake of 300 shares — an estimated $20.8K sold.

Cascade Investment Advisors first reported a position in BMY in Q2 2016 and held it in 19 quarters. The position peaked at $2.01M in Q1 2022. 2,481 funds tracked by Wall St. Rank hold BMY as of Q2 2023.

Cascade Investment Advisors reported no remaining Bristol-Myers Squibb position as of Q2 2023 after selling out during the quarter.
Cascade Investment Advisors sold 300 Bristol-Myers Squibb shares in Q2 2023, an estimated $20.8K.
Cascade Investment Advisors first reported a position in Bristol-Myers Squibb in Q2 2016 and held it in 19 quarters.
Cascade Investment Advisors's Bristol-Myers Squibb position peaked at $2.01M in Q1 2022.
2,481 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2023.

Based on Cascade Investment Advisors's 13F filing for Q2 2023, filed 21 Jul 2023.